ATE277181T1 - Tuberkulose-impfstoff - Google Patents

Tuberkulose-impfstoff

Info

Publication number
ATE277181T1
ATE277181T1 AT94919574T AT94919574T ATE277181T1 AT E277181 T1 ATE277181 T1 AT E277181T1 AT 94919574 T AT94919574 T AT 94919574T AT 94919574 T AT94919574 T AT 94919574T AT E277181 T1 ATE277181 T1 AT E277181T1
Authority
AT
Austria
Prior art keywords
tuberculosis
mycobacterium
mpt64
vaccination
polypeptide
Prior art date
Application number
AT94919574T
Other languages
English (en)
Inventor
Peter Andersen
Ase Bengaard Andersen
Kare Haslov
Anne Lund Sorensen
Original Assignee
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Seruminstitut filed Critical Statens Seruminstitut
Application granted granted Critical
Publication of ATE277181T1 publication Critical patent/ATE277181T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94919574T 1993-07-02 1994-07-01 Tuberkulose-impfstoff ATE277181T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93798A DK79893D0 (da) 1993-07-02 1993-07-02 New vaccine
PCT/DK1994/000273 WO1995001441A1 (en) 1993-07-02 1994-07-01 Tuberculosis vaccine

Publications (1)

Publication Number Publication Date
ATE277181T1 true ATE277181T1 (de) 2004-10-15

Family

ID=8097685

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94919574T ATE277181T1 (de) 1993-07-02 1994-07-01 Tuberkulose-impfstoff

Country Status (10)

Country Link
EP (2) EP0706571B1 (de)
AT (1) ATE277181T1 (de)
AU (1) AU682879B2 (de)
CA (1) CA2165949C (de)
DE (1) DE69434021T2 (de)
DK (2) DK79893D0 (de)
ES (1) ES2229220T3 (de)
NZ (1) NZ267984A (de)
PT (1) PT706571E (de)
WO (1) WO1995001441A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6641814B1 (en) 1997-04-02 2003-11-04 Statens Serum Institut Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis
US7300660B2 (en) 1993-11-23 2007-11-27 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
WO1995014713A2 (en) 1993-11-23 1995-06-01 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
MX9801687A (es) * 1995-09-01 1998-11-29 Corixa Corp Compuestos y metodos para el diagnostico de tuberculosis.
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
AU765833B2 (en) * 1995-09-01 2003-10-02 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
EP1712629A3 (de) * 1995-09-01 2009-09-09 Corixa Corporation Verbindungen und Verfahren zur Diagnose von Tuberkulose
BR9610262B1 (pt) * 1995-09-01 2013-11-26 Compostos e métodos para a imunoterapia e diagnose de tuberculose.
GB9526178D0 (en) 1995-12-21 1996-02-21 Taylor John Hermon Novel polynuceotides and polypeptides in pathogenic mycobacteria and their use as diagnostics,vaccines and targets for chemotherapy
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
PL333304A1 (en) * 1996-10-11 1999-11-22 Corixa Corp Techniques and methods of tuberculosis diagnosis
GB9624456D0 (en) 1996-11-25 1997-01-15 Isis Innovation Assay method
US6544522B1 (en) * 1998-12-30 2003-04-08 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
ATE370236T1 (de) * 1997-04-02 2007-09-15 Statens Seruminstitut Nukleinsäure- und polypeptidfragmente von m. tuberculosis
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
EP1029053A1 (de) * 1997-11-10 2000-08-23 Statens Seruminstitut Nukleinsäurefragmente und polypeptide von mycobacterium tuberculosis
WO1999045119A2 (en) * 1998-03-06 1999-09-10 Statens Serum Institut Production of mycobacterial polypeptides by lactic acid bacteria
GB9806093D0 (en) 1998-03-20 1998-05-20 Taylor John Hermon Diagnostics and vaccines for mycobacterial infections of animals and humans
NZ507378A (en) * 1998-04-07 2002-12-20 Corixa Corp Fusion proteins of mycobacterium tuberculosis antigens and their uses
CN1350546A (zh) 1998-11-04 2002-05-22 Isis创新有限公司 结核诊断测验
US20020131976A1 (en) 1998-12-23 2002-09-19 Ajit Lalvani Tuberculosis vaccine
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
AU4537100A (en) * 1999-05-12 2000-12-05 Statens Serum Institut Adjuvant combinations for immunization composition and vaccines
US6649170B1 (en) 1999-05-12 2003-11-18 Statens Serum Institut Adjuvant combinations for immunization composition and vaccines
CA2376723A1 (en) * 1999-06-18 2000-12-28 James G. Ferry Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases
US7288261B2 (en) * 2000-07-10 2007-10-30 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity
WO2004099771A1 (en) 2003-05-08 2004-11-18 Statens Serum Institut A new specific epitope based immunological diagnosis of tuberculosis
BRPI0518933A2 (pt) 2004-11-16 2008-12-16 Crucell Holland B V E Aeras Gl adenovÍrus recombinante defeituoso de replicaÇço, vetor de polinucleotÍdeo recombinante, vacina multivalente da tuberculose, e, uso do antÍgeno tb10.4 de mycobacterium
US8398991B2 (en) * 2005-06-22 2013-03-19 Institut Pasteur Modified ESAT-6 molecules and improved vaccine strains of Mycobacterium bovis BCG
CN100999550B (zh) 2006-01-10 2010-10-06 中国人民解放军第三○九医院 结核分枝杆菌融合蛋白及其应用
GB0618127D0 (en) * 2006-09-14 2006-10-25 Isis Innovation Biomarker
US20100150966A1 (en) 2007-05-08 2010-06-17 Prionics Ag Method for the diagnosis of tuberculosis
KR20220103823A (ko) 2014-10-23 2022-07-22 퀴아젠 사이언시스, 엘엘씨 펩티드 조성물 및 그의 용도
WO2016094574A1 (en) * 2014-12-09 2016-06-16 Board Of Regents, The University Of Texas System Tuberculosis vaccine compositions and related methods
CN106248934B (zh) * 2016-08-25 2018-04-06 中国疾病预防控制中心传染病预防控制所 结核分枝杆菌抗原蛋白Rv0446c及其T细胞表位肽的应用
CN106405107B (zh) * 2016-08-31 2018-04-06 中国疾病预防控制中心传染病预防控制所 结核分枝杆菌抗原蛋白Rv2941及其T细胞表位肽的应用
RU2631607C1 (ru) * 2016-11-22 2017-09-25 Владислав Николаевич Ласкавый Средство для профилактики лейкоза крупного рогатого скота и способ его применения

Also Published As

Publication number Publication date
ES2229220T3 (es) 2005-04-16
AU7068894A (en) 1995-01-24
NZ267984A (en) 1997-09-22
DE69434021T2 (de) 2005-09-01
DE69434021D1 (de) 2004-10-28
AU682879B2 (en) 1997-10-23
PT706571E (pt) 2005-02-28
DK79893D0 (da) 1993-07-02
CA2165949A1 (en) 1995-01-12
EP1508339A1 (de) 2005-02-23
EP0706571B1 (de) 2004-09-22
CA2165949C (en) 2011-06-07
DK0706571T3 (da) 2005-01-31
EP0706571A1 (de) 1996-04-17
WO1995001441A1 (en) 1995-01-12

Similar Documents

Publication Publication Date Title
DE69434021D1 (de) Tuberkulose-impfstoff
EP1523331B1 (de) Therapeutisches vakzin gegen tuberkulosis
WO1996015241A3 (en) A polynucleotide tuberculosis vaccine
PT2006395E (pt) Quadro de leitura aberto de m. tuberculosis rv2660c e suas utilizações
Husson et al. Genes for the major protein antigens of Mycobacterium tuberculosis: the etiologic agents of tuberculosis and leprosy share an immunodominant antigen.
ATE526994T1 (de) Mtb32a antigen aus mycobakterium tuberculosis mit inaktivierter protease aktivität und fusionsproteine die das antigen enthalten
WO2002004018A8 (en) Mid-life vaccine and methods for boosting anti-mycobacterial immunity
FI895050A0 (fi) Diagnostiska preparat och vaccin foer mykobakterier i folkhaelso-, medicinsk och veterinaermedicinsk praxis.
Vordermeier et al. Toward the development of diagnostic assays to discriminate between Mycobacterium bovis infection and bacille Calmette-Guerin vaccination in cattle
GB9409985D0 (en) Vaccine against mycobacterial infections
WO1997044463A3 (fr) Identification et clonage d'un antigene mycobacterien correspondant a une hemagglutinine de liaison a l'heparine
HK1081437A1 (en) Use of mycobacterial antigen mpb64 in the manufacture of a product for topical detection of active tuberculosis
Gilot et al. Comparative analysis of three sensitins used in cutaneous testing for tuberculosis and paratuberculosis in cattle
BAESS et al. Classification of Mycobacterium simiae by means of comparative reciprocal intradermal sensitin testing on guinea‐pigs and deoxyribonucleic acid hybridization
Hernandez-Pando et al. Recombinant BCG vaccine candidates
Teng et al. Immunogenicity of heparin-binding hemagglutinin expressed by Pichia pastoris GS115 strain
WO2000044392A3 (en) Identification of specific differentially expressed mycobacterial antigens
Borek Medical microbiology. vol. 2. Immunization against bacterial disease: edited by CSF Easmon and J. Jeljaszewicz. Academic Press, London, 1983 (304 pp., illus.)£ 32.00/$55.00
Singh et al. Mycobacterium phlei: A novel immunogenic strain against M. tuberculosis infection in experimental animals.
Ridell Crossreactivity between Mycobacterium leprae and various actinomycetes and related organisms
Lagrange et al. Experimental evaluation of factors conditioning the protective immunity in mycobacterial infections and related consequences for vaccination in humans.
Verma et al. Immunodominant antigens as biomarkers of Mycobacterium tuberculosis and M. bovis: Mini Review
Plouffe et al. Serological differences in Legionella pneumophila infections
Ridell et al. Immunodiffusion analyses of environmental mycobacteria isolated in Zaïre
CA2205175A1 (en) A polynucleotide tuberculosis vaccine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties